AI Healthcare Sector Surges Across the Board; MGI Tech (688114.SH), Bundling 'AI+Genes+Brain-Computer+Robot' Concepts, Jumps Over 23% in a Single Week

Stock News01-12

The AI healthcare sector has demonstrated strong performance recently, driven by OpenAI's launch of its ChatGPT Health feature and Ant Group's "A-Fu" surpassing 30 million monthly active users, leading to a broad-based rally. As a leading upstream player in life sciences, MGI Tech Co.,Ltd. (688114.SH) has become a core stock highly watched by the capital markets by bundling multiple hot concepts including smart healthcare, robotics, brain-computer interfaces, and synthetic biology. By the close of trading last Friday, MGI Tech's stock surged 10.21% in a single day, culminating in a cumulative weekly gain of 23.4%.

Within the AI healthcare field, MGI Tech holds a leading position with its "AI + gene sequencing" strategy. In recent years, the company has continuously advanced the upgrade of its Laboratory Intelligent Automation (GLI) business, comprehensively restructuring its laboratory automation operations through artificial intelligence technology and accelerating the development of AI-driven software tools to provide foundational support for its intelligent ecosystem. Regarding brain-computer interfaces, its Stereo-seq spatiotemporal omics technology can offer navigation support for implantable brain-computer interfaces with centimeter-level panoramic fields of view and nanometer-level resolution.

Currently, the company is collaborating with top-tier institutions such as the Shanghai Center for Brain Science and Brain-Inspired Intelligence, deeply participating in the major scientific initiative "Whole-Brain Mesoscopic Connectivity Atlas." According to a report from Grand View Research, the global AI in healthcare market size was approximately $26.65 billion in 2024 and is projected to skyrocket to roughly $505.59 billion by 2033, representing a compound annual growth rate of 38.8% during the period.

Compounded by the positive news of MGI Tech's formal inclusion in the CSI A500 Index on January 6th, the company is well-positioned to continuously unleash its growth potential within the trillion-yuan AI healthcare赛道, leveraging its comprehensive full-industry-chain layout.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment